Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$8.31
-6.0%
$3.91
$2.90
$170.63
$6.15M-0.18531,313 shs397,197 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.12
-2.8%
$0.15
$0.06
$6.00
$2.57M0.43579,909 shs112,486 shs
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$0.24
+0.4%
$0.27
$0.16
$4.76
$2.61M-0.724.51 million shs371,767 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
+6.51%+145.56%+151.85%+123.80%-99.89%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-5.78%-8.73%-11.74%+4.58%-97.41%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-3.40%-3.28%+5.08%-23.87%-93.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
2.3616 of 5 stars
3.55.00.00.00.60.00.6
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.4122 of 5 stars
3.05.00.00.00.00.00.0
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.345 of 5 stars
0.02.00.00.01.10.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARDMQ
Aradigm
0.00
N/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.00
Buy$50.00501.68% Upside
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.00
Hold$5.003,998.36% Upside
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ARDMQ, TTOO, VTAK, and NDRA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/21/2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $50.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$4.77 per shareN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.33N/AN/A($6.91) per share-0.02
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$420K6.22N/AN/A$1.33 per share0.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARDMQ
Aradigm
N/AN/A0.00N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08MN/A0.00N/A-563.16%N/A-174.06%7/28/2025 (Estimated)
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-$16.64MN/A0.00N/AN/A-3,744.91%-153.90%-68.25%8/13/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARDMQ
Aradigm
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARDMQ
Aradigm
N/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
3.85
3.85
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
N/A
0.21
0.19

Institutional Ownership

CompanyInstitutional Ownership
ARDMQ
Aradigm
N/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
20.34%

Insider Ownership

CompanyInsider Ownership
ARDMQ
Aradigm
4.50%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.04%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
2.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
ARDMQ
Aradigm
2315.28 millionN/ANot Optionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
20740,000738,000Not Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionOptionable
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
1411.02 million10.69 millionN/A

Recent News About These Companies

Catheter Precision, Inc. Receives CE Mark for LockeT

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aradigm OTCMKTS:ARDMQ

$0.05 0.00 (0.00%)
As of 06/30/2020

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

ENDRA Life Sciences stock logo

ENDRA Life Sciences NASDAQ:NDRA

$8.31 -0.53 (-6.00%)
As of 03:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.12 0.00 (-2.79%)
As of 03:03 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Catheter Precision stock logo

Catheter Precision NYSEAMERICAN:VTAK

$0.24 +0.00 (+0.42%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.